Gene · 407014
Papers3,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic analyses of a novel circRNA-related miRNAs prognostic signature for Cervical Cancer. | Genet Mol Biol | 2022 | 35766420 | PubTator, text mining | PubMed |
| A novel cross-species differential tumor classification method based on exosome-derived microRNA biomarkers established by human-dog lymphoid and mammary tumor cell lines' transcription profiles. | Vet World | 2022 | 35765483 | PubTator, text mining | PubMed |
| Advances in biomarkers and techniques for pancreatic cancer diagnosis. | Cancer Cell Int | 2022 | 35761336 | PubTator, text mining | PubMed |
| miRNA Involvement in Cerebral Ischemia-Reperfusion Injury. | Front Neurosci | 2022 | 35757539 | PubTator, text mining | PubMed |
| Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target. | Front Cardiovasc Med | 2022 | 35757325 | PubTator, text mining | PubMed |
| Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials. | Signal Transduct Target Ther | 2022 | 35752619 | PubTator, text mining | PubMed |
| Exosomal MicroRNA as Biomarkers for Diagnosing or Monitoring the Progression of Ovarian Clear Cell Carcinoma: A Pilot Study. | Molecules | 2022 | 35745075 | PubTator, text mining | PubMed |
| Anti-Cancer Effects of Dietary Polyphenols via ROS-Mediated Pathway with Their Modulation of MicroRNAs. | Molecules | 2022 | 35744941 | PubTator, text mining | PubMed |
| ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance. | Int J Mol Sci | 2022 | 35743145 | PubTator, text mining | PubMed |
| The Regulatory Roles of Mitochondrial Calcium and the Mitochondrial Calcium Uniporter in Tumor Cells. | Int J Mol Sci | 2022 | 35743109 | PubTator, text mining | PubMed |
| Non-Coding RNA Networks as Potential Novel Biomarker and Therapeutic Target for Sepsis and Sepsis-Related Multi-Organ Failure. | Diagnostics (Basel) | 2022 | 35741168 | PubTator, text mining | PubMed |
| HypoxaMIRs: Key Regulators of Hallmarks of Colorectal Cancer. | Cells | 2022 | 35741024 | PubTator, text mining | PubMed |
| The Impact of General Anesthesia on Redox Stability and Epigenetic Inflammation Pathways: Crosstalk on Perioperative Antioxidant Therapy. | Cells | 2022 | 35741011 | PubTator, text mining | PubMed |
| LncRNA-Dependent Mechanisms of Transforming Growth Factor-β: From Tissue Fibrosis to Cancer Progression. | Noncoding RNA | 2022 | 35736633 | PubTator, text mining | PubMed |
| HIF-1α Regulated WTAP Overexpression Promoting the Warburg Effect of Ovarian Cancer by m6A-Dependent Manner. | J Immunol Res | 2022 | 35733918 | PubTator, text mining | PubMed |
| GCN5 participates in KLF4-VEGFA feedback to promote endometrial angiogenesis. | iScience | 2022 | 35733790 | PubTator, text mining | PubMed |
| MiR-4739 inhibits the malignant behavior of esophageal squamous cell carcinoma cells via the homeobox C10/vascular endothelial growth factor A/phosphatidylinositol 3-kinase/AKT pathway. | Bioengineered | 2022 | 35730500 | PubTator, text mining | PubMed |
| Predicting miRNA-disease associations based on graph attention network with multi-source information. | BMC Bioinformatics | 2022 | 35729531 | PubTator, text mining | PubMed |
| SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma. | Front Immunol | 2022 | 35720314 | PubTator, text mining | PubMed |
| High Mobility Group Proteins in Sepsis. | Front Immunol | 2022 | 35720285 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407014/papers?page=32